Generation of monospecific peptide antibodies to the DNA binding domain of p53

K. Huppi*, D. Henderson, D. Siwarski, J. Hochman, M. Bergel, G. Tuchscherer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The DNA binding domain (DBD) is the most mutated region of p53 in tumors and has proven to be relatively resistant to the generation of specific antibodies. Template assembled synthetic peptide (TASP) synthesis of a peptide derived from the DBD creates a highly immunogenic molecule without the need for large carriers such as keyhole limpet hemocyanin (KLH). In addition, a rapid means of generating monoclonal antibodies can be achieved through immunization in conjunction with ABL/MYC retrovirus injection into recipient mice. In this paper, we demonstrate that an antibody generated by this means, KH2, reacts specifically with the DBD of p53. To date, this is the first example of a peptide immunogen used successfully in ABL/MYC monoclonal antibody production. KH2 is also the first example of a monospecific antibody that directly binds to and, by definition, assumes the conformation of the DNA binding region of p53.

Original languageEnglish
Pages (from-to)1100-1106
Number of pages7
JournalBioTechniques
Volume29
Issue number5
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Generation of monospecific peptide antibodies to the DNA binding domain of p53'. Together they form a unique fingerprint.

Cite this